• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Tekla Healthcare Investors

+ Add to Watchlist

XHQHX:US

32.76 USD 0.26 0.80%

As of 09:29:30 ET on 12/19/2014.

Snapshot for Tekla Healthcare Investors (XHQHX)

Year To Date: +36.88% 3-Month: +13.92% 3-Year: +40.54% 52-Week Range: 24.77 - 32.76
1-Month: +5.93% 1-Year: +40.08% 5-Year: +27.32% Beta vs BTK: 0.81

Mutual Fund Chart for XHQHX

No chart data available.
  • XHQHX:US 32.76
  • 1M
  • 1Y
Interactive XHQHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XHQHX

Tekla Healthcare Investors Fund is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.

Inception Date: 04-22-1987 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for XHQHX

NAV (on 2014-12-19) 32.76
Assets (M) (on 2014-12-19) 1,173.49
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for XHQHX

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-11-24) 0.59
Dividend Yield (ttm) 6.71

Fees & Expenses for XHQHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.95
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.13

Top Fund Holdings for XHQHX

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 1,039,942 78,151,641 10.619%
Celgene Corp 706,182 59,658,255 8.106%
Regeneron Pharmaceuticals Inc 178,740 49,196,398 6.685%
Biogen Idec Inc 132,195 36,981,551 5.025%
Alexion Pharmaceuticals Inc 259,405 34,516,429 4.690%
Amgen Inc 286,769 32,737,549 4.448%
Actavis plc 158,892 26,693,856 3.627%
Vertex Pharmaceuticals Inc 346,735 25,762,411 3.501%
Perrigo Co PLC 154,896 23,770,340 3.230%
iShares Nasdaq Biotechnology E 97,826 22,212,372 3.018%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil